Skin Cell DNA Synthesis Suppression

Skin cell DNA synthesis suppression refers to the inhibition or downregulation of the process by which skin cells (primarily keratinocytes in the epidermis) replicate their DNA, a critical step for cell division and proliferation. This process can be targeted pharmacologically or physiologically to control abnormal skin growth, such as in cancer or hyperproliferative disorders. Key molecules involved include DNA polymerases (e.g., Polη), translesion synthesis (TLS) polymerases, epigenetic modifiers (e.g., DNMT inhibitors), and cell cycle regulators (cyclins, CDKs). Pharmacological agents like bleomycin and theophylline can suppress DNA synthesis. This suppression is clinically relevant in cancer therapy and the treatment of hyperproliferative conditions but requires careful consideration due to potential toxicity toward normal cells.

Inhibition of DNA replication enzymes and cell cycle regulators, epigenetic modulation.